Back to the Top
The following message was posted to: PharmPK
Dear all,
Why usually 1. sponsors for BE study ( drugs with
long half life) do not prefer for parallel design,
they prefer cross over design.
2. sponsors do not prefer trunacted study
for long half life drugs.
regards,
Dr.Sridhar
|
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Study design - Drugs with Long half life" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)